Sitagliptin Grindeks

Medicinal product

(Invented) name

Sitagliptin Grindeks

Active substance (s)

Sitagliptinas

Strength

25 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A10BH01, Sitagliptin

Marketing authorisation holder

AS Grindeks, Latvija

Date of authorisation

2022-02-03

Date of renewal

Documents

4896_4898 Sitagliptin Grindeks PL 2024 11 04, VRA.docx

4896_4898 Pakuotės lapelis 2024 11 04, VRA.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

SE/H/2114/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Sitagliptinas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108036	94140	1094140	lizdinė plokštelė	N28		Receptinis	LT/1/22/4896/001	Netiekiama	-	-	No	-	-
108037	94141	1094141	lizdinė plokštelė	N56		Receptinis	LT/1/22/4896/002	Netiekiama	-	-	No	-	-
108038	94142	1094142	lizdinė plokštelė	N98		Receptinis	LT/1/22/4896/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-02-03	Registruotas